Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
- Status
- COMPLETED
- Phase
- N/A
Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine
- Status
- COMPLETED
- Phase
- N/A
Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Phase IIB Pilot of Atazanavir + Raltegravir
- Status
- TERMINATED
- Phase
- PHASE2